By Joshua Waimberg, JD Beginning in the early 2000s, there was a push in the public health world for jurisdictions and localities in the United States to adopt a Health in All Policies (HiAP) approach similar to recent initiatives in Europe. At its core, HiAP is a collaborative approach to improve the public’s health by…
By Temple University Center for Public Health Law Research CPHLR is joining forces with the Association of Schools and Programs of Public Health (ASPPH) for a free, two-part webinar series on public health law research and policy data evaluation. Public Health Law Research Part I: Creating and Using Open-Source Policy Data for Public Health Evaluation…
By Temple University Center for Public Health Law Research Join the Policy Surveillance Program for our new monthly webinar series teaching introductory and advanced policy surveillance techniques and applications. Learn more and register today for our one-hour sessions!
By Temple University Center for Public Health Law Research Join us for the 2017 Policy Surveillance Summer Institute. Learn more and register today! Space is limited and registration closes on May 1.
By Jonathan Larsen, JD, MPP and Adrienne R. Ghorashi, Esq. The US Food and Drug Administration (FDA) approved the first biosimilar for use in the United States in March 2015. The approval came after several years of regulatory process development authorized by the Biologics Price Competition and Innovation (BPCI) Act of 2009, a component of…
By Temple University Center for Public Health Law Research Medical personnel are trained to “first do no harm.” In end-of-life treatment, that simple directive can be difficult to interpret, and the legal landscape has evolved in the United States over the past 25 years. In 1990, the US Supreme Court ruled that physicians and other…
By Temple University Center for Public Health Law Research According to the Centers for Disease Control and Prevention, more than 6.4 million US children 4-17 years old have been diagnosed with attention-deficit/hyperactivity disorder (ADHD). The percentage of US children diagnosed with ADHD has increased by 3-5 percent per year since the 1990s. Relatedly, the percentage…
By Temple University Center for Public Health Law Research LEARN MORE and REGISTER!
By Arielle Lusardi As state medical marijuana laws proliferate throughout the country, companies are trying to secure their own piece of the action. In July 2014, a San Francisco-based start-up company, called Eaze, launched a mobile application that facilitates the delivery of medical marijuana in California.
By Holly Jones How can the federal government ensure consumer safety in an industry that distributes a substance the federal government classifies as an illegal drug? The federal government effectively banned the use of marijuana nationwide with the Controlled Substance Act of 1970, classifying marijuana as a Schedule I substance according. Regardless of this federal…
